The Cigna Group CI
Analyst Ratings
- Consensus
- Buy — 13 Buy · 4 Hold · 0 Sell (17 analysts)
- Avg. Price Target
- $342.88 (+24.6% upside)
Key Stats
- Today's Range
- $273.74 – $277.72
- 50-Day Range
- $263.11 – $305.44
- 52-Week Range
- $239.51 – $315.47
- Volume
- 2.33 million shs
- Average Volume
- 1.45 million shs
- Market Cap
- $72.93 billion
- P/E Ratio
- 11.38
- Dividend Yield
- 2.27%
Valuation
- P/E Ratio
- 11.38
- Price / Book
- 1.70
- Price / Sales
- 0.26
Dividend
- Dividend Yield
- 2.27%
- Annual Dividend
- $6.24
- Payout Ratio
- 25.80%
- Ex-Dividend Date
- 2026-09-08
Short Interest
- Short Interest
- 1.14%
- Days to Cover
- 2.80
Financials (TTM)
- Revenue
- $282.38 billion
- Net Income
- $6.98 billion
- Net Margin
- 2.47%
- Return on Equity
- 16.27%
- Debt-to-Equity
- —
About The Cigna Group
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
Related Stocks
Compare head-to-head: CI vs UNH·CI vs MOH·CI vs CLOV·CI vs ALHC
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.